Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer Meeting Abstract
| Authors: | Forde, P. M.; Smith, K.; Chaft, J. E.; Hellmann, M. D.; Merghoub, T.; Wolchok, J. D.; Yang, S. C.; Battafarano, R. J.; Gabrielson, E.; Georgiades, C.; Verde, F.; Rosner, G. L.; Anagnostou, V.; Velculescu, V. E.; Topalian, S. L.; Pardoll, D. M.; Brahmer, J. R. |
| Abstract Title: | Neoadjuvant anti-PD1, nivolumab, in early stage resectable non-small-cell lung cancer |
| Meeting Title: | 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 34 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2016 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2016-05-20 |
| Language: | English |
| ACCESSION: | WOS:000404711506061 |
| DOI: | 10.1200/JCO.2016.34.15_suppl.e20005 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: e20005 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
